We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet-based Conversational Engagement Clinical Trial (I-CONECT)

This study is not yet open for participant recruitment.
Verified September 2017 by Hiroko H. Dodge, Oregon Health and Science University
Sponsor:
ClinicalTrials.gov Identifier:
NCT02871921
First Posted: August 18, 2016
Last Update Posted: October 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
University of Michigan
National Institute on Aging (NIA)
Wayne State University
Information provided by (Responsible Party):
Hiroko H. Dodge, Oregon Health and Science University
August 8, 2016
August 18, 2016
October 3, 2017
January 2018
July 2020   (Final data collection date for primary outcome measure)
  • Intervention Efficacy [ Time Frame: Change from baseline cognitive test scores at 6 months ]
    Examine the intervention's efficacy using cognitive test scores of executive and memory functions using the National Alzheimer's Coordinating Center Uniform Data Set Neuropsychological Battery
  • Intervention Efficacy [ Time Frame: Change from baseline cognitive test scores at 12 months ]
    Examine the intervention's efficacy using cognitive test scores of executive and memory functions using the National Alzheimer's Coordinating Center Uniform Data Set Neuropsychological Battery
  • Intervention Efficacy [ Time Frame: Change from baseline cognitive test scores at 6 months ]
    Examine the intervention's efficacy using cognitive test scores of executive and memory functions using the National Alzheimer's Coordinating Center Uniform Data Set Battery
  • Intervention Efficacy [ Time Frame: Change from baseline cognitive test scores at 12 months ]
    Examine the intervention's efficacy using cognitive test scores of executive and memory functions using the National Alzheimer's Coordinating Center Uniform Data Set Battery
Complete list of historical versions of study NCT02871921 on ClinicalTrials.gov Archive Site
  • Exploratory Analysis of Cognitive Tests [ Time Frame: Change from baseline NIH toolbox cognitive test scores at 6 months ]
    Examine the intervention's efficacy on the same cognitive domains (executive and memory functions) using the NIH-Toolbox computerized cognitive test battery for cross-validation of domain responsiveness of our intervention.
  • Exploratory Analysis of Cognitive Tests [ Time Frame: Change from baseline NIH toolbox cognitive test scores at 12 months ]
    Examine the intervention's efficacy on the same cognitive domains (executive and memory functions) using the NIH-Toolbox computerized cognitive test battery for cross-validation of domain responsiveness of our intervention.
  • Underlying Mechanisms of Efficacy [ Time Frame: Change from baseline at 6 months ]
    Examine region specific structural and functional pre-post changes in brain using magnetic resonance imaging (MRI)
  • Exploratory Analysis of Speech and Language Characteristics [ Time Frame: Change from baseline at 6 months ]
    Examine whether the intervention could lead to changes in speech and language characteristics over time by analyzing recorded video chats in the experimental group
  • Exploratory Analysis of Speech and Language Characteristics [ Time Frame: Change from baseline at 12 months ]
    Examine whether the intervention could lead to changes in speech and language characteristics over time by analyzing recorded video chats in the experimental group
  • Examine translational effects of improvements in cognitive functions in medication adherence [ Time Frame: Change from baseline at 6 months ]
    Two ecologically valid functional outcome measures sensitive to trial effects have been chosen: the Revised Observational Tasks of Daily Living (OTDL-R) and a MedTracker device that monitors in-home daily medication adherence.
  • Examine translational effects of improvements in cognitive functions in medication adherence [ Time Frame: Change from baseline at 12 months ]
    Two ecologically valid functional outcome measures sensitive to trial effects have been chosen: the Revised Observational Tasks of Daily Living (OTDL-R) and a MedTracker device that monitors in-home daily medication adherence.
  • Exploratory Analysis of Cognitive Tests [ Time Frame: Change from baseline NIH toolbox cognitive test scores at 6 months ]
    Examine the intervention's efficacy on the same cognitive domains (executive and memory functions) using the NIH-Toolbox computerized cognitive test battery for cross-validation of domain responsiveness of our intervention.
  • Exploratory Analysis of Cognitive Tests [ Time Frame: Change from baseline NIH toolbox cognitive test scores at 12 months ]
    Examine the intervention's efficacy on the same cognitive domains (executive and memory functions) using the NIH-Toolbox computerized cognitive test battery for cross-validation of domain responsiveness of our intervention.
  • Underlying Mechanisms of Efficacy [ Time Frame: Change from baseline at 6 months ]
    Examine region specific structural and functional pre-post changes in brain using magnetic resonance imaging (MRI)
Not Provided
Not Provided
 
Internet-based Conversational Engagement Clinical Trial
Internet-based Conversational Engagement Clinical Trial
At each site (OHSU & UM), 180 socially isolated adults 80+ years old will be recruited through Meals on Wheels People. Participants will be randomized to either the Video Chat Group or the Control Group. Those in the Video Chat Group will receive a computer for the duration of the study, which they will use to video chat with study staff for 30 minutes/day 4x/week for 6 months, and then they will video chat 2x/week for another 6 months. Those assigned to the Control Group will have brief telephone check-ins with study staff once per week. In-home testing will occur at Baseline, 6 months and 12 months. All participants at OHSU will have their medication compliance tracked using electronic medication monitoring devices (MedTracker) and 50% of participants at both OHSU and UM will have MRIs at Baseline and 6 months, if they are able to safely receive MRIs. All participants at both sites will contribute saliva for genetic testing, and all video chat sessions will be recorded for speech and language analysis.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
  • Aging
  • Mild Cognitive Impairment
Behavioral: Conversational Engagement
Examine whether increasing social interaction through face-to-face conversations could improve cognitive functions, targeting seniors aged 80 and older who are socially isolated
  • Experimental: Conversational Engagement
    Participants engage in 30-minute face-to-face communications with study staff through internet/webcam 4 times per week for 24 weeks (6 months), followed by sustaining dose of 2 times per week of 30 minutes session for additional 24 weeks (6 months). Conversational staff will facilitate content-standardized but naturalistic-style social engagement. Staff and participants will engage in conversation about a wide variety of topics that are culturally and personally relevant and interesting to participants. Each day, participants will be able to choose from two topics.
    Intervention: Behavioral: Conversational Engagement
  • No Intervention: Control Group
    Participants will receive a phone call once per week that lasts less than 10 minutes; interviewers ask brief questions to monitor their social activities and health conditions

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
360
July 2021
July 2020   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 80 or older;
  • Living alone;
  • Marital status of widowed, widower or single;
  • Socially isolated based on social isolation score;
  • Not severely depressed;
  • Willing to undergo MRI (if physically possible) and contribute saliva for genetic testing;
  • Living independently (independent in any items in Old Americans Resources and services Programs (OARS) Activities of Daily Living (ADL), (partial assistance in items in OARS Instrumental Activities of Daily Living (IADL) are allowed);
  • Normal cognition or early Mild Cognitive Impairment, determined by neuropsychological testing and consensus diagnoses by neuropsychologists at Alzheimer's Disease Centers;
  • Adequate vision and hearing to use study technology and undergo testing;
  • Sufficient ability to understand English in order to complete the testing and engage in conversation with study staff;

Exclusion Criteria:

  • Plans to start taking classes, travel, or attend significant social events during the intervention period;
  • Disease associated with dementia;
  • Significant disease of the central nervous system;
  • Current or recent alcohol or substance abuse;
  • Major psychiatric disorder;
  • Unstable or significantly symptomatic cardiovascular disease;
  • Unstable insulin-dependent diabetes mellitus;
  • Active or recent systemic cancer;
  • Any illness that requires >1 visit per month to a clinician;
  • Progressive vision loss that is already beginning to significantly degrade vision;
  • Need for oxygen supplementation;
  • Frequent use of high doses of analgesics;
  • Sedative medications other than those used occasionally for sleep.
Sexes Eligible for Study: All
80 Years and older   (Senior)
Yes
Contact: Elena Goodrich, BA 503.494.9043 goodrice@ohsu.edu
Not Provided
 
 
NCT02871921
STUDY00015937
R56AG056102 ( U.S. NIH Grant/Contract )
R01AG051628 ( U.S. NIH Grant/Contract )
Yes
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: Undecided
Hiroko H. Dodge, Oregon Health and Science University
Oregon Health and Science University
  • University of Michigan
  • National Institute on Aging (NIA)
  • Wayne State University
Principal Investigator: Hiroko Dodge, PhD Oregon Health and Science Univeristy
Oregon Health and Science University
September 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP